Adverse events after botulinum A toxin injection for neurogenic voiding disorders
نویسندگان
چکیده
منابع مشابه
Use of botulinum toxin for voiding dysfunction
The use of botulinum toxin A (BoNT-A) has expanded across a range of lower urinary tract conditions. This review provides an overview of the current indications for BoNT-A in the lower urinary tract and critically evaluates the published evidence within each area. The classic application of BoNT-A has been in the management of refractory neurogenic detrusor overactivity (NDO) and overactive bla...
متن کاملBotulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction
Voiding dysfunction due to detrusor underactivity or urethral sphincter dysfunction is a treatment challenge for urologists. Recently, urologists have used botulinum toxin A (BoNT-A) injection into the urethral sphincter to treat voiding dysfunction. This treatment has been found to decrease urethral pressure and postvoid residual volume, and increase voiding efficiency in patients with neuroge...
متن کاملFailure of botulinum toxin injection for neurogenic detrusor overactivity: Switch of toxin versus second injection of the same toxin.
OBJECTIVES To evaluate the efficacy of a second injection of the same toxin versus switching to a different botulinum toxin A after failure of a first detrusor injection in patients with neurogenic detrusor overactivity. METHODS The charts of all patients who underwent detrusor injections of botulinum toxin A (either abobotulinumtoxinA or onabotulinumtoxinA) for the management of neurogenic d...
متن کاملBotulinum Toxin Injection
Adductor spasmod.ic dysphonia is a vocal disorder of uncertain etiology with no satisfactory long-term treatment-result. Recently injecrton of Botulinum toxin (BOTOX) into the thyroarytenoid muscle has been used as an effective temporary treatment. In this experiment, 9 partents with adductor spasmodic dysphonia (SPD) were studicd and injected percutaneously the Bonlinum toxin with dose of inje...
متن کاملGastric peroral endoscopic myotomy for gastroparesis, after botulinum toxin injection.
A 45-year-old woman had refractory Epstein–Barr virus-associated gastroparesis. Despite lifestyle modification and medication therapy, the patient had recurrent hospitalizations for gastroparesis. Management also included four previous sessions of endoscopic botulinum toxin injection. Despite transient symptomatic improvement, the patient’s symptoms had recurred. She was not a candidate for sur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Spinal Cord
سال: 2005
ISSN: 1362-4393,1476-5624
DOI: 10.1038/sj.sc.3101736